SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-305010
Filing Date
2020-11-30
Accepted
2020-11-30 08:15:28
Documents
3
Period of Report
2020-11-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d11581d8k.htm 8-K 21647
2 EX-99.1 d11581dex991.htm EX-99.1 14321
3 GRAPHIC g11581g1129230844017.jpg GRAPHIC 2267
  Complete submission text file 0001193125-20-305010.txt   40429
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 201356329
SIC: 2836 Biological Products, (No Diagnostic Substances)